• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 27 of 100
CVS Health is about to turn hundreds of its drugstores into health care super-clinics
HealthCVS Health is about to turn hundreds of its drugstores into health care super-clinics
By Shawn TullyOctober 4, 2021
Pfizer vaccine
HealthWhat comes next for COVID booster shots after the FDA panel hedges on Pfizer
By Sy MukherjeeSeptember 17, 2021
Kids at school in masks
Health3 things you should know about the timeline for kids’ COVID vaccines
By Sy MukherjeeSeptember 16, 2021
White House unveils plan to lower prescription drug prices
PoliticsWhite House unveils plan to lower prescription drug prices
By Chris MorrisSeptember 9, 2021
Parkinson's lab grown synthetic mini brain
HealthParkinson’s disease has no approved treatment. Scientists want to use lab grown mini-brains to change that
By Sy MukherjeeSeptember 8, 2021
Demonstration against the Purdue pharmaceutical bankruptcy deal in White Plains, New York
HealthSackler family to pay fine of $4.5 billion as OxyContin maker Purdue Pharma is dissolved
By Jeff Mulvihill and The Associated PressSeptember 1, 2021
AC Immune shares surge on Alzheimer’s drug trial results
HealthAC Immune shares surge on Alzheimer’s drug trial results
By Naomi Kresge, James Paton and BloombergAugust 31, 2021
The mystery drugs President Biden didn’t name during his speech on prescription meds
PoliticsThe mystery drugs President Biden didn’t name during his speech on prescription meds
By Geoff ColvinAugust 18, 2021
A woman in Bangladesh receiving a COVID-19 vaccine
HealthOn the hunt for a ‘universal’ COVID-19 vaccine as Delta variant surges
By Jeremy KahnAugust 18, 2021
The politics behind President Biden’s plan to lower prescription drug prices
PoliticsThe politics behind President Biden’s plan to lower prescription drug prices
By Geoff ColvinAugust 14, 2021
Pharmacies face extra audit burdens that threaten their existence
HealthPharmacies face extra audit burdens that threaten their existence
By Markian Hawryluk and Kaiser Health NewsAugust 6, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
FinanceEli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
Image of a predicted protein structure rom the malaria parasite
HealthIn giant leap for biology, DeepMind’s A.I. reveals secret building blocks of human life
By Jeremy KahnJuly 22, 2021
A picture of a protein shape.
TechDeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By Jeremy KahnJuly 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
AI
Anthropic disables Fable and Mythos AI models after U.S. government bars it from giving foreigners accessplaceholder alt text
By Jeremy KahnJune 13, 2026
Startups & Venture
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'placeholder alt text
By Emma HinchliffeJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.